Generic:

Tranexamic acid

Therapeutic Class:

Antifibrinolytic

Composition:

Each capsule of Maxna contains 500 mg tranexamic acid.
Each 5 ml ampoule of Maxna contains 500 mg or 1gm of of tranexamic acid.

Description:

Maxna contains tranexamic acid,
an antifibrinolytic agent, used to treat or prevent haemorrhage in a
variety of bleeding disorders.

Indications:

• Dysfunctional uterine bleeding (DUB)
• Menorrhagia
• Ante- & post-partum hemorrhages

Dosage:

Capsules:
The usual adult dose of capsule is 500 mg three or four times daily depending on the severity of the condition.

Injection:
For patients unable to take oral medication, Maxna injection can be administered in a dose of 10 mg/kg bodyweight 3 to 4 times daily.

Presentations:

• 500 mg caps 20’s,
• 500 mg Inj 10’s,
• 1 gm Inj 10’s,